NCT05783284View on ClinicalTrials.gov

HS2 US Liver Reader Study

CompletedOBSERVATIONAL

Enrollment

22

Participants

Timeline

Start Date

March 2, 2023

Primary Completion Date

March 4, 2023

Study Completion Date

March 4, 2023

Conditions

Reader Study

Interventions

DEVICE

Holocare Studio 2 (HS2)

3D HV

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors

lead

HoloCare AS

INDUSTRY